drugset / Trial / NCT04275024

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

NCT04275024

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Adipose derived Mesenchymal Stem Cells (AD-MSCs) plus Calpocitriol Ointment and PSORI-CM01 Granule with moderate to severe psoriasis. Any adverse events related to AD-MSCs infusion will be monitored.The primary outcome is the reduction rate of PASI(Psoriasis Area and Severity Index) and treatment response will be computed from PASI before and after treatment.

Timeline

Start
2020-04-01
Primary completion
2020-06-17
Completion
2021-02-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Adipose-Derived Mesenchymal Stromal Cells Cell therapy 2 cells/kg Intravenous
Background Calcipotriol Small molecule Topical
Background PSORI-CM01 Unknown 5.5 g Oral

Indications